[go: up one dir, main page]

IL195066A0 - Cancer-related nucleic acids - Google Patents

Cancer-related nucleic acids

Info

Publication number
IL195066A0
IL195066A0 IL195066A IL19506608A IL195066A0 IL 195066 A0 IL195066 A0 IL 195066A0 IL 195066 A IL195066 A IL 195066A IL 19506608 A IL19506608 A IL 19506608A IL 195066 A0 IL195066 A0 IL 195066A0
Authority
IL
Israel
Prior art keywords
cancer
nucleic acids
related nucleic
acids
nucleic
Prior art date
Application number
IL195066A
Original Assignee
Rosetta Genomics Ltd
Ranit Aharonov
Nitzsn Rosenfeld
Hila Benjamin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/418,875 external-priority patent/US7592441B2/en
Priority claimed from US11/418,718 external-priority patent/US20070259349A1/en
Priority claimed from US11/418,870 external-priority patent/US7825229B2/en
Priority claimed from US11/429,720 external-priority patent/US7642348B2/en
Application filed by Rosetta Genomics Ltd, Ranit Aharonov, Nitzsn Rosenfeld, Hila Benjamin filed Critical Rosetta Genomics Ltd
Publication of IL195066A0 publication Critical patent/IL195066A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL195066A 2006-05-04 2008-11-03 Cancer-related nucleic acids IL195066A0 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US11/418,875 US7592441B2 (en) 2004-10-04 2006-05-04 Liver cancer-related nucleic acids
US11/418,718 US20070259349A1 (en) 2006-05-04 2006-05-04 Bladder cancer-related nucleic acids
US11/418,870 US7825229B2 (en) 2005-03-25 2006-05-04 Lung cancer-related nucleic acids
US11/429,720 US7642348B2 (en) 2004-10-04 2006-05-08 Prostate cancer-related nucleic acids
US82524706P 2006-09-11 2006-09-11
PCT/IB2007/003116 WO2007148235A2 (en) 2006-05-04 2007-05-04 Cancer-related nucleic acids

Publications (1)

Publication Number Publication Date
IL195066A0 true IL195066A0 (en) 2011-08-01

Family

ID=38833834

Family Applications (1)

Application Number Title Priority Date Filing Date
IL195066A IL195066A0 (en) 2006-05-04 2008-11-03 Cancer-related nucleic acids

Country Status (2)

Country Link
IL (1) IL195066A0 (en)
WO (1) WO2007148235A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563252B2 (en) 2004-05-14 2013-10-22 Rosetta Genomics Ltd. Methods for distinguishing between lung squamous carcinoma and other non small cell lung cancers
JP2010519899A (en) * 2007-03-01 2010-06-10 ロゼッタ ゲノミックス エルティーディー． Methods to distinguish lung squamous cell carcinoma from other non-small cell lung cancer
WO2009119809A1 (en) * 2008-03-27 2009-10-01 株式会社ミラキュア Marker for determination of breast cancer, test method, and test kit
EP2281903B1 (en) * 2008-04-30 2017-01-04 NEC Corporation METHOD FOR EVALUATION OF CANCER BY USING miRNA CANCER MARKER
US9068232B2 (en) * 2008-08-06 2015-06-30 Rosetta Genomics Ltd. Gene expression signature for classification of kidney tumors
US20110160086A1 (en) * 2008-08-06 2011-06-30 Rosetta Genomics Ltd. Gene expression signature for classification of kidney tumors
WO2010018563A2 (en) * 2008-08-12 2010-02-18 Rosetta Genomics Ltd. Compositions and methods for the prognosis of lymphoma
WO2010022166A2 (en) * 2008-08-19 2010-02-25 Maine Institute For Human Genetics And Health Micro rna (mirna) and neurofibromatosis type 1 : a role in diagnosis and therapy
US20120053224A1 (en) * 2008-12-10 2012-03-01 Universitat Regensburg Compositions and methods for micro-rna expression profiling of cancer stem cells
EP2419538B1 (en) * 2009-04-16 2016-09-14 Padma Arunachalam Methods and compositions to detect and differentiate small rnas in rna maturation pathway
EP2460005A4 (en) * 2009-07-31 2012-11-21 Translational Genomics Res Inst METHODS OF EVALUATING THE RISK OF PROGRESSION OF CANCER
WO2011024157A1 (en) * 2009-08-23 2011-03-03 Rosetta Genomics Ltd. Nucleic acid sequences related to cancer
WO2011108930A1 (en) * 2010-03-04 2011-09-09 Interna Technologies Bv A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT
BR112012024590A2 (en) 2010-03-29 2016-05-31 Abraxis Bioscience Inc methods of enhancing drug release and efficacy of therapeutic agents
WO2011154008A1 (en) 2010-06-11 2011-12-15 Rigshospitalet Microrna classification of thyroid follicular neoplasia
JP5755849B2 (en) * 2010-07-06 2015-07-29 東レ株式会社 Composition or kit for determining sensitivity to adjuvant chemotherapy for gastric cancer
US10150999B2 (en) 2010-11-17 2018-12-11 Interpace Diagnostics, Llc miRNAs as biomarkers for distinguishing benign from malignant thyroid neoplasms
JP6011945B2 (en) * 2011-05-20 2016-10-25 公一 中城 Composition comprising microRNA or expression system thereof
ITRM20110685A1 (en) 2011-12-23 2013-06-24 Internat Ct For Genetic En Gineering And MICRORNA FOR CARDIAC REGENERATION THROUGH THE INDUCTION OF THE PROLIFERATION OF CARDIAC MYCYCLES
WO2017073689A1 (en) * 2015-10-30 2017-05-04 国立大学法人鳥取大学 Rna molecule for repairing dna damage

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2530157B1 (en) * 2003-07-31 2016-09-28 Regulus Therapeutics Inc. Oligomeric compounds and compositions for use in modulation of miRNAs

Also Published As

Publication number Publication date
WO2007148235A2 (en) 2007-12-27
WO2007148235A3 (en) 2009-04-30

Similar Documents

Publication Publication Date Title
IL195066A0 (en) Cancer-related nucleic acids
GB0706243D0 (en) Modified nucleic acids
IL194892A0 (en) Nonseparation assay methods
PL2021778T3 (en) Nonseparation assay methods
EP2123752A4 (en) Novel nucleic acid
EP2077326A4 (en) Novel nucleic acid
PL2041282T3 (en) Sdf-i binding nucleic acids
GB2456119B (en) Heating system
EP2017608A4 (en) Biosensor
IL196268A0 (en) Assay methods
GB0603160D0 (en) Nucleic acid
PL2017607T3 (en) Biosensor
GB0603224D0 (en) Spoiler
GB0720672D0 (en) Assay method
GB0619208D0 (en) Easy tile
GB0624302D0 (en) Micro RNA
GB0602061D0 (en) Heater
GB0706631D0 (en) Nucleic acids and libraries
GB0622144D0 (en) Biosensor
GB0624301D0 (en) Micro RNA
EP1981985A4 (en) Microarray methods
PT1918649T (en) Heating system
HU0600159D0 (en) Kvantitative pcr
GB0602625D0 (en) DNA structures
GB0602718D0 (en) Nucleic Acid Manipulation